December 25, 2014 7:16 AM ET

Pharmaceuticals

Company Overview of Sanofi-Topaz Inc.

Executive Profile

Thomas R. Beck M.D.

Chief Medical Officer, Sanofi-Topaz Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
64--

Background

Dr. Thomas R. Beck, also known as Tom, M.D. is an Executive Partner of Fidelity Biosciences. Dr. Beck joined Fidelity Biosciences in September 2007. Dr. Beck serves as Chief Medical Officer of Topaz Pharmaceuticals. He has been a Consultant at Dyax Corp. since May 2007. Dr. Beck served as Chief Executive Officer of CytoMed, Inc. He served as interim Chief Executive Officer of Dimension Therapeutics, Inc from October 31, 2013 to September 2014. Most recently, Dr. Beck ...

Corporate Headquarters

100 Witmer Road
Horsham, Pennsylvania 19044

United States

Phone: 267-960-3330
Fax: 267-960-3331

Board Members Memberships

Director
Director
2010-Present
Director
2013-2014
Former Interim Chief Executive Officer and Director

Education

MD
Cornell University
BS
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanofi-Topaz Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.